Therefore, our study implicates a unique role of Src/ezrin in regulating local invasion of breast carcinoma cells, and provides a clinically relevant model for assessing the potential of this pathway as a prognostic biomarker or a predictive marker for treatment response or relapse. The gene discussed is EZR; the disease is breast carcinoma.